PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
78881722 |
LAW OFFICE ASSIGNED |
LAW OFFICE 113 |
MARK SECTION |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
FOLOTYN |
OWNER SECTION (current) |
NAME |
Allos Therapeutics, Inc. |
STREET |
11080 Circle Point Road, Suite 200 |
CITY |
Westminster |
STATE |
Colorado |
ZIP/POSTAL CODE |
80020 |
COUNTRY |
United States |
PHONE |
(303) 426-6262 |
FAX |
(303) 426-4731 |
OWNER SECTION (proposed) |
NAME |
Allos Therapeutics, Inc. |
STREET |
11080 Circle Point Road, Suite 200 |
CITY |
Westminster |
STATE |
Colorado |
ZIP/POSTAL CODE |
80020 |
COUNTRY |
United States |
PHONE |
(303) 426-6262 |
FAX |
(303) 426-4731 |
EMAIL |
XXXX |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceuticals and pharmaceutical preparations for the treatment of cancer |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
4 |
ONGOING EFFORT |
product or service research development; market research |
ALLOWANCE MAIL DATE |
03/27/2007 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/TD Bratschun/ |
SIGNATORY'S NAME |
Thomas D. Bratschun |
SIGNATORY'S POSITION |
Attorney |
DATE SIGNED |
03/12/2009 |
FILING INFORMATION |
SUBMIT DATE |
Thu Mar 12 17:29:08 EDT 2009 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XX.XXX-
20090312172908746841-7888
1722-4406a7cea10b6c64a973
3757b9f4228d0c6-CC-3099-2
0090312170512908052 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: FOLOTYN
SERIAL NUMBER: 78881722
The applicant, Allos Therapeutics, Inc., having an address of
11080 Circle Point Road, Suite 200
Westminster, Colorado 80020
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 03/27/2007.
For International Class 005:
Current identification: Pharmaceuticals and pharmaceutical preparations for the treatment of cancer
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development; market research
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /TD Bratschun/ Date Signed: 03/12/2009
Signatory's Name: Thomas D. Bratschun
Signatory's Position: Attorney
RAM Sale Number: 3099
RAM Accounting Date: 03/13/2009
Serial Number: 78881722
Internet Transmission Date: Thu Mar 12 17:29:08 EDT 2009
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.XXX-200903121729087
46841-78881722-4406a7cea10b6c64a9733757b
9f4228d0c6-CC-3099-20090312170512908052